Prediction of Uterine Atony After Vaginal Delivery by Elastography
NCT ID: NCT04267783
Last Updated: 2020-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2019-05-01
2020-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of HI-RTE Elasticity in Obstetric
NCT01032564
Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications
NCT03052686
The Role of Ultrasonography in Labor in Predicting the Outcomes of Childbirth
NCT06806904
EMG for Uterotonic Efficiency Estimation
NCT04201665
Effect of Uterine Massage Versus Sustained Uterine Compression on Blood Loss After Vaginal Delivery
NCT02396771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shear wave elastography
Investigate the feasibility of use of shear-wave elastography of the uterus during the third stage of labour and following placental delivery in order to predict uterine atony .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cephalic presentation
* maternal age \> 18 years old
* nulliparous
* healthy uncomplicated pregnancy
* gestational age between 37-42 weeks of gestation
* spontaneous labour and delivery
* uncomplicated progression of labour (cervical dilatation at \>1 cm/h)
* administration of less than 3 units of oxytocin during the second stage of labour
* patient having read, accepted and signed the consent form
Exclusion Criteria
* protracted second stage of labour (more than two hours from full dilatation to delivery)
* more than 30 minutes of active pushing
* BMI \> 35 kg/m2
* distance from skin to uterus \> 8 cm
* age \> 35 years old
* instrumental deliveries
* bleeding disorders
* polyhydramnios
* diabetes
* pre-eclampsia
* high blood pressure
* use of anticoagulant medications
* clinical chorioamnionitis
* placental abnormality (low-lying or abruption)
* fetal macrosomia
* uterine fibroids
* uterine anomalies
* previous uterine scar
* multiple pregnancy
* placental retention
* inability to follow procedures or insufficient knowledge of project language
* inability to give consent
* refusal to participate
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Vaudois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DAVID DESSEAUVE
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Lausanne
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-02267
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.